Soji F Oluwole1, Ayoola O Ali, Zahra Shafaee, Hector A DePaz. 1. Department of Surgery, Harlem Hospital Center, College of Physicians and Surgeons of Columbia University, New York, New York 10037, USA. so5@columbia.edu
Abstract
BACKGROUND: The association of human immunodeficiency virus (HIV) infection with breast carcinoma is unclear. With improved survival of HIV-infected patients due to better understanding and treatment of the disease, there is likely to be an increase in incidence of breast cancer in women with HIV infection. METHODS: The medical records of 305 patients with breast cancer seen between January 1995 and December 2000 at Harlem Hospital Center, New York, where approximately 1,000 HIV-infected patients are treated yearly, were reviewed with attention to age, breast cancer stage at presentation, and patient survival. RESULTS: Breast cancer in the five HIV-infected patients has same median age distribution, disease stage, and pathologic characteristics as in the 300 HIV-indeterminate patients. Four of the five (80%) HIV-infected women compared to 79% in the HIV-indeterminate patients presented with early breast cancer (Stages I and II). Five-year survival in the HIV-infected patients is 80%, which is similar to the observed 70% 5-year crude survival rate in the indeterminate group. CONCLUSIONS: Our results do not support the recent reports suggesting that HIV infection is associated with poorly differentiated, aggressive disease with poor survival outcome. It remains unclear if breast carcinoma is directly linked to HIV infection.
BACKGROUND: The association of human immunodeficiency virus (HIV) infection with breast carcinoma is unclear. With improved survival of HIV-infectedpatients due to better understanding and treatment of the disease, there is likely to be an increase in incidence of breast cancer in women with HIV infection. METHODS: The medical records of 305 patients with breast cancer seen between January 1995 and December 2000 at Harlem Hospital Center, New York, where approximately 1,000 HIV-infectedpatients are treated yearly, were reviewed with attention to age, breast cancer stage at presentation, and patient survival. RESULTS:Breast cancer in the five HIV-infectedpatients has same median age distribution, disease stage, and pathologic characteristics as in the 300 HIV-indeterminate patients. Four of the five (80%) HIV-infectedwomen compared to 79% in the HIV-indeterminate patients presented with early breast cancer (Stages I and II). Five-year survival in the HIV-infectedpatients is 80%, which is similar to the observed 70% 5-year crude survival rate in the indeterminate group. CONCLUSIONS: Our results do not support the recent reports suggesting that HIV infection is associated with poorly differentiated, aggressive disease with poor survival outcome. It remains unclear if breast carcinoma is directly linked to HIV infection.
Authors: John F Deeken; Angelique Tjen-A-Looi; Michelle A Rudek; Catherine Okuliar; Mary Young; Richard F Little; Bruce J Dezube Journal: Clin Infect Dis Date: 2012-07-09 Impact factor: 9.079
Authors: Sukhwant N Singh; Yue Zhu; Saranya Chumsri; Susan Kesmodel; Bruce L Gilliam; David J Riedel Journal: Clin Breast Cancer Date: 2013-11-20 Impact factor: 3.225
Authors: Akhilesh K Sista; Robert J Knebel; Sidhartha Tavri; Magnus Johansson; David G DeNardo; Sophie E Boddington; Sirish A Kishore; Celina Ansari; Verena Reinhart; Fergus V Coakley; Lisa M Coussens; Heike E Daldrup-Link Journal: J Transl Med Date: 2009-11-11 Impact factor: 5.531